Current Medicinal Chemistry

Results: 45



#Item
11Ontario Pharmacists Association New Business Application Application Information a)  Membership no. (must be current)

Ontario Pharmacists Association New Business Application Application Information a) Membership no. (must be current)

Add to Reading List

Source URL: www.opatoday.com

Language: English - Date: 2014-04-17 10:44:15
12Fox Chase Chemical Diversity Center, Inc. Drug Discovery Research Collaborator Translating biomedical research into commercial opportunities

Fox Chase Chemical Diversity Center, Inc. Drug Discovery Research Collaborator Translating biomedical research into commercial opportunities

Add to Reading List

Source URL: www.fc-cdci.com

Language: English - Date: 2014-07-22 14:17:42
13U.S. Food and Drug Administration  Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may

U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may

Add to Reading List

Source URL: www.fda.gov

Language: English
14U.S. Food and Drug Administration  Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may

U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may

Add to Reading List

Source URL: www.fda.gov

Language: English
15U.S. Food and Drug Administration  Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may

U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may

Add to Reading List

Source URL: www.fda.gov

Language: English
16U.S. Food and Drug Administration  Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may

U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may

Add to Reading List

Source URL: www.fda.gov

Language: English
17U.S. Food and Drug Administration  Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may

U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may

Add to Reading List

Source URL: www.fda.gov

Language: English
18Promoting Innovation in Drug Development: Understanding the Current Regulatory Environment Nicholas S. Downing, MD (with Nilay D. Shah, PhD; Harlan M. Krumholz, MD, SM; and Joseph S. Ross, MD, MHS) Project Summary for IS

Promoting Innovation in Drug Development: Understanding the Current Regulatory Environment Nicholas S. Downing, MD (with Nilay D. Shah, PhD; Harlan M. Krumholz, MD, SM; and Joseph S. Ross, MD, MHS) Project Summary for IS

Add to Reading List

Source URL: isps.yale.edu

Language: English - Date: 2014-07-17 11:15:56
19CURRENT SCIENCE Volume 107 Number[removed]August 2014

CURRENT SCIENCE Volume 107 Number[removed]August 2014

Add to Reading List

Source URL: www.currentscience.ac.in

Language: English - Date: 2014-08-05 10:08:36
20SECURITIES AND EXCHANGE COMMISSION Washington, D.C[removed]FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

SECURITIES AND EXCHANGE COMMISSION Washington, D.C[removed]FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Add to Reading List

Source URL: www.corgenix.com

Language: English - Date: 2013-09-11 09:31:48